During the past decade, Hospital Clínico de Valladolid conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 12 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 7 clinical trials were completed. i.e. 24.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Clínico de Valladolid" #1 sponsor was "PETHEMA Foundation" with 11 trials, followed by "Ipsen" with 6 trials sponsored, "Boston Scientific Corporation" with 5 trials sponsored, "Hospital Clínico Universitario de Valladolid" with 5 trials sponsored and "Amgen" with 5 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 45 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clínico de Valladolid" #1 collaborator was "Hospital Clínico Universitario de Valladolid" with 2 trials as a collaborator, "University of Valladolid" with 2 trials as a collaborator, "Anagram" with 1 trials as a collaborator, "Apices Soluciones S.L." with 1 trials as a collaborator and "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Clínico de Valladolid" are "Acute Lymphoblastic Leukemia" (5 trials), "Aortic Valve Stenosis" (4 trials), "Acute Stroke" (3 trials), "Migraine" (3 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "Hospital Clínico de Valladolid" in a lesser frequency.

Most popular intervention types in "Hospital Clínico de Valladolid" are "Drug" (35 trials), "Device" (13 trials), "Other" (10 trials), "Procedure" (6 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Cyclophosphamide" (3 trials), "Daunorubicin" (3 trials), "Mercaptopurine" (3 trials) and "Methotrexate" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clínico de Valladolid" are 71 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Clínico de Valladolid". undefined are not yet recruiting, 14 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Hospital Clínico de Valladolid, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clínico de Valladolid, 5 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 10 trials that are defined as “Not Applicable".

Hospital Clínico de Valladolid has several departments that took part in Clinical trials: "Hospital Clinico Universitario de Valladolid; Servicio de Oncologia" - 4 trials